Form 4: NeuroPace Director Rakhi Kumar Increases Stake Through Equity Compensation

NeuroPace Inc. Director Rakhi Kumar has increased her direct beneficial ownership of common stock through a series of acquisitions as part of the company's non-employee director compensation policy.

Summary

• Rakhi Kumar, a Director at NeuroPace Inc. (NPCE), reported multiple acquisitions of common stock.
• These acquisitions occurred on various dates from June 30, 2023, to June 21, 2025.
• The shares were issued to Ms. Kumar pursuant to NeuroPace's non-employee director compensation policy, in lieu of quarterly retainer fees.
• On June 30, 2023, 3,340 shares were acquired at $4.49 per share, bringing total beneficial ownership to 3,340 shares.
• On September 29, 2023, 1,541 shares were acquired at $9.73 per share, increasing total beneficial ownership to 4,881 shares.
• On December 29, 2023, 1,454 shares were acquired at $10.31 per share, increasing total beneficial ownership to 6,335 shares.
• On March 29, 2024, 1,136 shares were acquired at $13.20 per share, increasing total beneficial ownership to 7,471 shares.
• On June 28, 2024, 1,984 shares were acquired at $7.56 per share, increasing total beneficial ownership to 9,455 shares.
• On September 30, 2024, 2,152 shares were acquired at $6.97 per share, increasing total beneficial ownership to 11,607 shares.
• On December 21, 2024, 1,300 shares were acquired at $11.53 per share, increasing total beneficial ownership to 12,907 shares.
• On March 21, 2025, 1,247 shares were acquired at $12.02 per share, increasing total beneficial ownership to 14,154 shares.
• On June 21, 2025, 1,440 shares were acquired at $10.41 per share, increasing total beneficial ownership to 15,594 shares.

Sentiment

Score: 7

Explanation: The sentiment is positive as a director is increasing their stake in the company, which generally signals confidence. However, it's a routine compensation event rather than an open market purchase, so the positive signal is moderate.

Positives

• A director increasing their direct beneficial ownership of company stock can signal confidence in the company's future prospects.
• The consistent acquisition of shares as part of compensation aligns the director's interests with those of shareholders.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future performance.

Industry Context

This filing is a routine disclosure of insider transactions, common across all publicly traded companies, and does not provide specific insights into broader industry trends for medical devices or neurological treatments. It reflects standard compensation practices for non-employee directors.

Comparison to Industry Standards

• The practice of compensating non-employee directors with equity (shares) in lieu of or in addition to cash retainer fees is a common corporate governance practice across various industries, including healthcare and technology.
• The approximate quarterly value of shares issued (around $15,000) is within a typical range for non-executive director compensation at companies of similar market capitalization and stage of development as NeuroPace.

Corporate Governance

Related Party Transactions

• The acquisition of shares by Director Rakhi Kumar as compensation falls under related party transactions, as it involves a transaction between the company and a member of its board of directors.

Stakeholder Impact

• Shareholders: Increased alignment of director's interests with shareholders due to higher equity ownership.
• Management: Reinforces the company's compensation structure for non-employee directors.

Key Dates

Keywords

NeuroPace, NPCE, Rakhi Kumar, Director, Insider Trading, SEC Form 4, Stock Acquisition, Equity Compensation, Beneficial Ownership